- Home
- NAGE vs CFBK Comparison
NAGE vs CFBK Comparison
Compare NAGE & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NAGE | CFBK |
|---|---|---|
| Founded | 1999 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 212.8M | 219.7M |
| IPO Year | 2010 | 2005 |
Fundamental Metrics
Financial Performance| Metric | NAGE | CFBK |
|---|---|---|
| Price | $2.07 | $35.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $10.67 | N/A |
| AVG Volume (30 Days) | ★ 518.4K | 36.5K |
| Earning Date | 11-04-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 1.02% |
| EPS Growth | ★ 81.82 | 30.58 |
| EPS | 0.07 | ★ 2.59 |
| Revenue | ★ $129,423,000.00 | N/A |
| Revenue This Year | N/A | $7.47 |
| Revenue Next Year | $15.79 | $12.52 |
| P/E Ratio | $30.50 | ★ $13.59 |
| Revenue Growth | ★ 29.95 | N/A |
| 52 Week Low | $2.04 | $22.59 |
| 52 Week High | $7.12 | $38.11 |
Technical Indicators
Market Signals| Indicator | NAGE | CFBK |
|---|---|---|
| Relative Strength Index (RSI) | 35.09 | 59.30 |
| Support Level | $2.04 | $33.46 |
| Resistance Level | $3.61 | $35.49 |
| Average True Range (ATR) | 0.13 | 0.79 |
| MACD | -0.01 | 0.08 |
| Stochastic Oscillator | 5.41 | 75.84 |
Price Performance
Historical ComparisonAbout NAGE Niagen Bioscience Inc.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
About CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans, and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.